Skip to content

22 min read

Science Breakthroughs This Week: 1-7 October 2026, Scored

The science breakthroughs of 1-7 October 2026, scored: 29 new peer-reviewed results, led by biomedicine, with mitochondria across the tree of life on top at 74.

By The Frontier Desk. Scores quoted are live Frontier Scores; see how they are computed.

A recurring, evidence-scored roundup of the newest science on the Frontier index.

29 new breakthroughs went live on Frontier between 1 and 7 October 2026, and biomedicine led them with 15.

Every entry in this issue is a primary research result traced to its source and scored from 0 to 100 on three axes: Evidence, Impact and Novelty. All 29 are peer-reviewed journal papers, published between 22 September and 5 October, and together they are everything added to the index since the previous Dispatch. Sixteen appeared in four of the five general flagship journals: Nature (8), Science (3), Cell (3) and the New England Journal of Medicine (2). Scores ran from 60 to 74 (58 to 76 last issue), and only two results reached 70.

Both come from one project. The top entry (Frontier Score 74) compares mitochondrial proteomes across the tree of life, and the runner-up (72) maps the mitochondria of Acanthamoeba, an amoeba that causes infectious blindness; with a third paper, on the model plant Arabidopsis (68), they appeared in Cell on 1 October from the MitoCarta Tree of Life project. Next come butterfly wing patterns that, the authors propose, mislead predators in flight (69), a study of how confidence steers what people encode from what they see (69), and a white dwarf that appears to be feeding on the atmosphere of a candidate planet formed late in its star's life (68).

The two largest clinical trials, both in the New England Journal of Medicine, scored lower: TRIUMPH-1 of the weekly obesity injection retatrutide (61, with mean weight loss of up to 25.0% over 80 weeks) and the NHS-Galleri trial of a multi-cancer blood test (63, with no significant drop in late-stage diagnoses). Section 2 explains why.

Biomedicine and health led with 15 entries, then neuroscience (5), AI and computing (3), space and materials (2 each), and climate and our cross-disciplinary other frontiers (1 each); no physics or quantum paper joined. Scores are as of 7 October; the index re-scores entries as evidence moves, so a live page can differ.

1. The top of the table, in depth

The 8 results that scored 68 or above, in score order, each linked to its Frontier entry and to the paper.

Comparative analysis of mitochondrial proteomes across the tree of life

Frontier Score 74 · Biomedicine & Health · Cell

Mitochondria arose about 2 billion years ago from the endosymbiosis of a bacterium with an archaea-related host cell. To trace their evolution, the authors compared the experimentally defined mitochondrial proteomes of eight organisms, identifying 8,619 distinct proteins in 3,199 families, 43% of which lack Pfam domains. A classifier based on a protein language model, retrained on these inventories, then predicted the mitochondrial proteomes of about 200 eukaryotes, from which the authors reconstructed that of the last eukaryotic common ancestor (LECA).

The reconstruction indicates that LECA already had a complex mitochondrion capable of both aerobic and anaerobic metabolism. Since then, lineages have ranged from clade-specific expansions of gene families to extreme reductions that seem headed for losing the organelle. The comparison also finds 33 protein families conserved in eukaryotic pathogens but absent in humans, which the authors present as candidate drug targets; none is validated yet, and most of the 200 inventories are predictions. Frontier entry · Paper

Mitochondrial proteome of Acanthamoeba delineates aerobic and anaerobic pathways dynamically regulated by oxygen

Frontier Score 72 · Biomedicine & Health · Cell

Acanthamoeba castellanii causes infectious blindness and sits in a key evolutionary outgroup to humans and fungi. Combining two mitochondrial purification methods with mass spectrometry, protein correlation profiling and microscopy, the authors built AcMitoCarta, a high-confidence inventory of 1,122 proteins, 381 of which lack readily identifiable homologs in human and yeast mitochondria.

Oxygen extensively rewires this machinery. Without it, the amoeba induces an anaerobic pathway running from pyruvate:ferredoxin oxidoreductase to a hydrogenase, and the authors show experimentally that it can produce hydrogen gas under anoxic conditions through an oxygen-sensitive hydrogenase in its mitochondria. The inventory covers one species, and the abstract reports no drug test against the pathways it maps. Frontier entry · Paper

Butterfly wing patterns in flight create powerful illusory motion cues

Frontier Score 69 · Biomedicine & Health · Nature

The function of butterflies' enormously diverse, high-contrast wing patterns has inspired intense theoretical debate. The authors propose that the patterns and flight together create visual illusions that confuse predators, with four lines of evidence: high-speed films of take-offs in free flight showing misleading motion cues; comparative analyses, controlled for evolutionary relationships, indicating the strategy is evolutionarily widespread; in silico evolution experiments that independently converge on butterfly-like patterns; and behavioural experiments that validate the models' predictions.

The dazzling stripes of zebras and snakes have long been thought to disrupt how predators perceive motion, a hypothesis with little empirical support. The authors call the effect potentially one of the most successful visual defence strategies among moving animals. The missing test is whether wild predators catch butterflies with stronger illusions less often. Frontier entry · Paper

Intrinsic rewards guide visual resource allocation via reinforcement learning

Frontier Score 69 · Neuroscience · Nature Human Behaviour

Humans and other animals prioritize processing what signals reward, but research has focused on tangible incentives such as money or food. This study tests an intrinsic one, perceived competence: across visual estimation experiments, the authors manipulated how confident observers felt, through deceptive feedback or real differences in stimulus reliability. Observers prioritized encoding the stimuli tied to lower uncertainty or error, which helped them where they were already accurate and further impaired them where they were not, lowering overall accuracy.

The authors reproduce the bias quantitatively by adding a simple reinforcement learning rule to a normalization model of neural resource allocation, in which intrinsic and external rewards together set the value of each stimulus. Whether the bias shapes performance outside such tasks is not tested here. Frontier entry · Paper

A high-confidence plant mitochondrial proteome via protein correlation profiling

Frontier Score 68 · Biomedicine & Health · Cell

Plant mitochondria share many features with animal ones but have traits of their own, from both circular and linear mitochondrial DNA to pathways that support photosynthesis. Combining serial mitochondrial enrichment, mass spectrometry and protein correlation profiling, the authors define 1,462 mitochondrial proteins experimentally; with the literature and microscopy validation, the result is AtMitoCarta, an atlas of 1,609 proteins for Arabidopsis thaliana, including 236 newly defined proteins and 147 of unknown function.

A comparison across eukaryotes shows that 15% of mitochondrial protein families are plant specific, including the expanded pentatricopeptide repeat proteins. The workflow can be applied to wild-type (unmodified) plants, which the authors say will enable comparative studies; what the new and unknown proteins do is the work ahead. Frontier entry · Paper

Deep learning of fossil pollen morphology reveals 25,000 y of ecological change in eastern African grasslands

Frontier Score 68 · Climate & Environment · PNAS

Most grass pollen cannot be told apart with traditional optical microscopy, so it has been largely overlooked in studies of how grasslands evolved. The authors trained convolutional neural networks on superresolution images of known modern and unlabeled fossil grass pollen, used the learned features to estimate diversity and to separate C3 from C4 grasses (two photosynthetic types), validated the method on modern pollen assemblages, and applied it to a 25,000-year lake-sediment record from Mt. Kenya.

The montane grasslands' species diversity declined substantially between 21,500 and 16,000 years ago, coinciding with the most severe regional cooling of the last ice age, and the share of C4 grasses gradually decreased after the transition into the Holocene, associated with higher temperatures and decreasing fire activity. It is one record, the ties to climate and fire are correlations in time, and the C3 and C4 classifier was validated on modern pollen. Frontier entry · Paper

Discovery of a second-generation planet candidate accreting onto a white dwarf

Frontier Score 68 · Space & Astronomy · Nature Astronomy

Many white dwarfs, the dense remnants of stars like the Sun, accrete the debris of disrupted planetary bodies, which, though diverse, has so far closely resembled Solar System bodies overall. HS 0209+0832 is accreting material unlike any of them: its atmosphere is strongly enriched in elements heavier than iron and depleted in silicon and iron. The authors read the high enrichment in s-process elements (made by slow neutron capture) as the mark of a candidate second-generation planet, formed from material the star ejected during its giant phase, and the helium and missing rock-forming elements as signs that the white dwarf is accreting the escaped atmosphere of an evaporating giant planet candidate.

A 4.4-day brightness variation of about 0.12% further supports the picture; the authors attribute it to a planetary day-night cycle or a transiting cometary tail. They present the discovery as showing that close-in planets can form around white dwarfs after a star's main-sequence life; it is one star, and the planet is a candidate. Frontier entry · Paper

Incorporation of atmospheric components in planetary magma oceans through bubble–metal compounds

Frontier Score 68 · Space & Astronomy · Science

Carbon, hydrogen and nitrogen (the atmophile elements) were thought to have accreted late in planet formation, yet cosmochemical and astrophysical evidence suggests they were already present while small bodies such as Vesta were forming, although magmatic heating should have outgassed them from bodies too small to retain them. In experiments on magma ocean-like mixtures, the authors found that gas bubbles attach strongly to metal droplets, forming bubble-metal compounds that resist segregation.

Under low gravity, compounds a millimeter to a centimeter across could have sunk, trapping those elements in the interior, and early flotation of such compounds would have enhanced the mantle's endowment of iron-loving (siderophile) elements, eliminating the need for late accretion. The compounds were observed in laboratory mixtures; their behaviour inside early planetary bodies is inferred. Frontier entry · Paper

2. The two big trials, and why they scored lower

The two largest clinical trials here, both randomized and both in the New England Journal of Medicine, enrolled 2,339 adults and more than 142,000 people, and both scored in the low 60s.

Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity

Frontier Score 61 · Biomedicine & Health · New England Journal of Medicine

Retatrutide activates the receptors for three hormones: GIP, GLP-1 and glucagon. In TRIUMPH-1, a phase 3, randomized, double-blind trial, 2,339 adults with obesity but without diabetes were assigned to a once-weekly injection of retatrutide (4, 9 or 12 mg) or placebo for 80 weeks. Body weight fell by a mean of 17.6% with 4 mg, 23.7% with 9 mg and 25.0% with 12 mg, against 3.9% with placebo; for the 9 mg and 12 mg doses, the ones the primary outcomes compared with placebo, the differences were 19.8 and 21.0 percentage points.

Two subgroups also improved (intention-to-treat results): in 574 participants with knee osteoarthritis, the 9 mg and 12 mg doses lowered the WOMAC pain score by 1.4 and 1.6 points more than placebo, and in 243 with obstructive sleep apnea they lowered the apnea-hypopnea index by 24.7 and 22.5 events per hour more. The trial was funded by Eli Lilly and did not include people with diabetes, and on safety the abstract reports only that the most common adverse events were gastrointestinal. Frontier entry · Paper

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

Frontier Score 63 · Biomedicine & Health · New England Journal of Medicine

In the NHS-Galleri randomized, controlled trial in England, people aged 50 to 77 gave blood at up to three annual visits; 71,122 were randomly assigned to have their blood tested for multiple cancers, on top of usual care, and 71,128 to have it stored. After three screening rounds and at least 12 months of follow-up, the incidence of stage III or IV cancer across 12 prespecified cancer types, the primary end point, did not differ significantly between the groups (incidence rate ratio 1.03, 95% confidence interval 0.92 to 1.14).

For stage IV cancer, a key secondary end point, the ratio was 0.86 (95% confidence interval 0.74 to 1.00), an interval that reaches 1.00, the value meaning no difference. Fewer than 1% of participants had trial-related adverse events, and none were serious. The end points the abstract reports concern stage at diagnosis, not deaths; the trial was funded by Grail, and the authors call for further follow-up. Frontier entry · Paper

Where the points went

The Frontier Score weighs Evidence, Impact and Novelty at 25%, 25% and 50%. Of the 13 points between the mitochondrial comparison and retatrutide, about 7 come from Novelty, 3 from Impact and 2 from Evidence. Both trials earn full marks for venue and are recorded by all five citation indices the score checks, but both papers are closed access, which holds their Verifiability at 45 out of 100 against 100 for the openly licensed mitochondrial paper, so their Evidence reads 83 against its 92. Impact, which reads how strongly a paper is being cited relative to its field, has barely begun for every entry in this issue: 38 for retatrutide, 46 for Galleri and 50 for the mitochondrial paper.

The largest gap is Novelty, half the score. Its lead signal, conceptual novelty, is read from a paper's own topics and references at publication. The main input is how predictable the paper's median pairing of research topics is: retatrutide's, diabetes treatment with the regulation of appetite and obesity, is a pairing 4,922 earlier works had made, far more often than chance would produce, which puts it at 25 out of 100. References can lift that number but never lower it, and retatrutide's, a median 3.3 years old, lift it to 34. Galleri's median pairing is less predictable (39), and its references, a median 2.5 years old, add nothing. The mitochondrial comparison pairs mitochondrial biology with protist diversity, a far less predictable mix (49), and references a median 8.9 years old lift it to 67.

Conceptual novelty is an honestly noisy measure, so it never drives the ranking alone. And none of this says the trials matter less: a mean weight loss of up to a quarter of body weight in a phase 3 trial, and a screening trial of more than 142,000 people that missed its primary end point, both bear directly on patients. The score asks a narrower question, how new and how well established a result is and how strongly it is being cited so far, and the Early signal label on all 29 entries says how much of the answer is still an estimate. Our ranking of the latest medical breakthroughs of 2026 scores 27 earlier medical results, from 2025 and 2026, as of 4 September.

3. Also new this week

The other 19 entries, by field, with each one's score and journal; each title links to its Frontier entry.

Biomedicine & Health: cancer

Biomedicine & Health: infection, immunity and the gut

Biomedicine & Health: evolution and metabolism

Neuroscience

AI & Computing

  • Scalable decision-making for games of imperfect information (67, Nature). Ataraxos, an AI for the board wargame Stratego, defeated the most decorated human player of all time by a large margin, to the authors' knowledge the game's first superhuman result, with orders of magnitude less compute and data than earlier efforts.
  • Function-preserving watermarking of AI-generated proteins (64, Nature). Google DeepMind's SynthIDBio embeds watermarks in AI-designed protein sequences without spoiling function: watermarked binders kept a binding affinity comparable with unwatermarked ones, and the mark was detected with near-perfect accuracy. The abstract reports no test against deliberate removal.
  • Toward a future space-based, highly scalable AI infrastructure system design (62, Joule). A Google design study for machine-learning compute on fleets of solar-powered satellites: Trillium TPUs survived a radiation dose equivalent to a five-year mission without permanent failures, and launch to low Earth orbit may reach $200/kg or less by the mid-2030s.

Materials & Energy

Other frontiers

  • Defensive networks provide basis for late pre-Hispanic Andean polities (66, PNAS). Network analyses of 1,287 hillforts found in a satellite survey of more than 150,000 km² of the south-central Andean highlands show larger, less cohesive defensive networks in open terrain and smaller, more cohesive ones in rugged terrain, broadly matching the political units known from independent sources.

4. What the week says

Mitochondria across life. Four entries are about the cell's powerhouse. The three Cell papers belong to the MitoCarta Tree of Life consortium, whose findings, announced on 1 October, appear in nine papers and a commentary across Cell and related journals - Broad Institute. Together they describe an organelle already complex in the last eukaryotic common ancestor and reshaped lineage by lineage since, and the fourth, in Science, finds a single carrier in fat cells where the clock, diet and temperature meet. The three proteome papers share one limit, coverage: eight organisms mapped by experiment, and the rest of the 200-eukaryote picture predicted.

Evolution at three speeds. Stickleback hybrids purged marine alleles at the main reproductive-isolation loci within a few generations of the 2011 tsunami, fish lineages colonized the tropical rivers of Australia and New Guinea over millions of years, and grasslands on Mt. Kenya lost diversity during the region's most severe cooling of the last ice age, while the butterfly study argues that high-contrast wing patterns are an evolutionarily widespread motion illusion. The first three each rest on one population, one region or one record.

Cancer from four directions. A p53-mutant clone taking over mouse skin, osteoclasts in a mouse model of dural metastasis, a WRN inhibitor in its first human trial and a multi-cancer blood test. None is a finished answer: two are mouse studies, one is a dose-escalation trial without a comparison group, and the screening trial missed its primary end point.

AI, studied and used. Three entries are about AI itself (a Stratego player its authors call superhuman, a watermark for AI-designed proteins and a design for AI compute in orbit, the last two from Google), and a fourth uses AI to read fossil pollen. Only the game result is measured against people; the watermark is a proof of concept and the orbital system a design study.

5. How these scores are built

The Frontier Score weighs Evidence (25%), Impact (25%) and Novelty (50%), then applies a recency factor under which a result keeps 75% of its standing at eight months old and never falls below half, so the active edge stays on top. A retraction collapses the score to zero, and a separate confidence label says how settled each result is: every entry in this issue reads Early signal, because its citation history has barely begun.

The index takes in up to four new papers a day from the leading journals, putting first the papers their journal ran a commentary on, such as a News & Views or a Perspective; the two NEJM trials were added by hand after a check of what the daily intake had missed, and a catch-up run added four more on 5 October. The full recipe, its sources and its limitations are on the methodology page, and our guide to the replication crisis explains how to judge a result this new. For the longer view, our ranking of the biggest scientific breakthroughs of 2026 scores the index as of 31 August. To get the week's best new results by email, subscribe to the Frontier Brief.

The Frontier Brief

The week's frontier, scored.

Every Monday, the highest-scoring new breakthroughs in the index, each with its score and a one-line read on why it matters. What you get

One email a week. The top new breakthroughs, scored. Unsubscribe anytime.

Science Breakthroughs This Week: 1-7 October 2026, Scored | Frontier